Jefferies Financial Group reiterated their hold rating on shares of Indivior (LON:INDV) in a research note published on Tuesday morning, ThisIsMoney.Co.Uk reports.
Shares of LON:INDV opened at GBX 83 ($1.02) on Tuesday. The stock has a market capitalization of $607.92 million and a price-to-earnings ratio of -6.38. Indivior has a 1-year low of GBX 32.90 ($0.40) and a 1-year high of GBX 89.16 ($1.10). The company has a debt-to-equity ratio of 730.77, a quick ratio of 1.64 and a current ratio of 1.75. The company has a 50 day moving average price of GBX 64.08 and a 200 day moving average price of GBX 48.07.
Indivior Company Profile
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence. The company's product pipeline focuses on treating opioid use disorder, alcohol use disorder, opiate overdose, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex.
Recommended Story: Which market index is the best?
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.